Dr. Edwin Y. Lin, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
12462 Putnam St
Whittier, CA 90602
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Southern California Keck School of Medicine (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 171
Licensed in California since 2006, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: University of Southern California Keck School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
CA license A94173 (first issued 2006; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Pih Health Hospital-Whittier Whittier, CA
- Pih Health Downey Hospital Downey, CA
Medical groups
- Pih Health Physicians (622 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 171
- Services billed
- 2,196
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 171 | 104 |
| Established patient office or other outpatient visit, 30-39 minutes | 166 | 85 |
| Injection of drug or substance under skin or into muscle | 155 | 28 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 148 | 23 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 113 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 91 | 36 |
| Insertion of needle into vein for collection of blood sample | 23 | 14 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 19 |
| Administration of influenza virus vaccine | 12 | 12 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anastrozole Other prescribers in Whittier, CA | 54 |
| Eliquis (apixaban) Other prescribers in Whittier, CA | 51 |
| Alendronate Sodium Other prescribers in Whittier, CA | 26 |
| Ondansetron Odt (ondansetron) Other prescribers in Whittier, CA | 21 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Whittier, CA | 17 |
| Gabapentin Other prescribers in Whittier, CA | 12 |
| Letrozole Other prescribers in Whittier, CA | 11 |
| Prochlorperazine Maleate Other prescribers in Whittier, CA | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 29 companies reported 63 payments worth $1,562 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $201 |
|---|---|
| Pfizer Inc. | $168 |
| Beone Medicines USA, Inc. | $131 |
| Merck Sharp & Dohme LLC | $120 |
| Puma Biotechnology, Inc. | $77.75 |
| Lilly USA, LLC | $68.14 |
| Janssen Biotech, Inc. | $64.79 |
| Geron Corporation | $54.00 |
| Food and Beverage | $1,518 |
|---|---|
| Education | $43.25 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 25, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $6,820 in research payments for these studies, mostly to the institutions running them.
- Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Mirati Therapeutics, Inc. · Active, not recruiting · NCT04793958
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.